CDP840. A prototype of a novel class of orally active anti-Inflammatory phosphodiesterase 4 inhibitors

Rakki P. Alexander, Graham J. Warrellow, Michael A. W. Eaton, EileenA. Boyd, John C. Head, Jc Porter, Julien A. Brown, James Reuberson, Brian Hutchinson, Paul Turner, Byron A. Boyce, David M. Barnes, B. Mason, A. Cannell, Russell J. Taylor, Albert Y. Zomaya, Andrew T. Millican, J. C. Leonard, Richard Morphy, Martin R. Wales, Maria de Jesus Perry, Rodger A. Allen, Neil Gozzard, B. Hughes, G.a. HiggsBioorganic 2002 · DOI

BibTeX
@inproceedings{alexander2002cdp,
  author = {Rakki P. Alexander and Graham J. Warrellow and Michael A. W. Eaton and EileenA. Boyd and John C. Head and JC Porter and Julien A. Brown and James Reuberson and Brian Hutchinson and Paul Turner and Byron A. Boyce and David M. Barnes and B. Mason and A. Cannell and Russell J. Taylor and Albert Y. Zomaya and Andrew T. Millican and J. C. Leonard and Richard Morphy and Martin R. Wales and Maria de Jesus Perry and Rodger A. Allen and Neil Gozzard and B. Hughes and G.A. Higgs},
  title = {{CDP840. A prototype of a novel class of orally active anti-Inflammatory phosphodiesterase 4 inhibitors}},
  booktitle = {Bioorganic},
  year = {2002},
  doi = {10.1016/s0960-894x(02)00202-0},
}

Loading related content...

Figure